Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct 28;6(4):82-85.
doi: 10.1002/cld.507. eCollection 2015 Oct.

Management of patients with hepatitis C virus resistance-associated variants to NS5A inhibitors: Where are we now?

Affiliations
Review

Management of patients with hepatitis C virus resistance-associated variants to NS5A inhibitors: Where are we now?

Jennifer T Wells et al. Clin Liver Dis (Hoboken). .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Multitargeted approach to HCV treatment based on the structure of the HCV protein. Adapted from McGovern et al.1 Abbreviation: UTR, untranslated region.

References

    1. McGovern BH, Abu Dayyeh BK, Chung RT. Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. Hepatology 2008;48:1700‐1712. - PubMed
    1. Blight KJ, Kolyhalov AA, Reed KE, Agapov EV, Rice CM. Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets. Antiviral Ther 1998;3:71‐81. - PubMed
    1. Tomei L, Failla C, Santolini E, De Francesco R, La Monica N. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol 1993;67:4017‐4026. - PMC - PubMed
    1. Lindenbach B, Rice CM. Unraveling hepatitis C virus replication from genome to function. Nature 2005;436:933‐938. - PubMed
    1. Kieffer TL. Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT‐Cs). J Antimicrob Chemother 2010;65:202‐212. - PubMed